Diagnostic performance of postoperative C-reactive protein for anastomotic leakage after elective laparoscopic colorectal resection

After surgery to remove a section of the bowel, the body's most immediate concern is often not the removal itself, but the delicate work of reconnecting the two ends. Surgeons stitch or staple the intestine back together, creating a new passage for waste. This connection is called an anastomosis. While modern techniques are highly refined, this junction remains a vulnerable spot. If the seal fails, intestinal contents can leak into the abdominal cavity, causing a severe infection known as an anastomotic leakage. This complication is dangerous, often requiring emergency surgery, prolonged hospital stays, and sometimes the creation of a temporary stoma to divert waste while the body heals. Because the symptoms of a leak can be subtle at first or appear days after the patient has gone home, doctors need a reliable way to know early on whether the connection is holding or failing.

For years, surgeons have looked to a simple blood test to help answer this question. The test measures C-reactive protein, a substance the liver produces when the body is fighting inflammation. After any major surgery, this level naturally rises as the body reacts to the trauma of the operation. In a healthy recovery, the level peaks a few days after the procedure and then steadily falls. However, if a leak occurs, the inflammation continues or worsens, keeping the levels high. The challenge has always been finding the exact point where a high level means "everything is fine" versus "something is wrong," as this number can vary depending on the type of surgery and the patient's condition.

A team of researchers at Hospital San Juan de Dios in Santiago, Chile, set out to solve this puzzle specifically for patients undergoing elective laparoscopic colorectal resection. This is a minimally invasive surgery where the bowel is removed and reconnected using small incisions and a camera, rather than a large open cut. The researchers followed hundreds of patients over several years, tracking their blood tests on the second, third, and fourth days after surgery. They wanted to see if a single blood test on a specific day could reliably tell them who was safe to go home and who needed closer monitoring.

The study focused on a group of 260 patients who had a straightforward laparoscopic procedure without any complications like conversion to open surgery or the creation of a protective stoma. By looking at this specific group, the researchers could isolate the signal of a leak from the noise of other surgical variables. They found that the blood test on the fourth day after surgery was remarkably accurate. On this day, the level of C-reactive protein in patients who had a leak was significantly higher than in those who did not. The researchers calculated a specific threshold: a level of 137.3 milligrams per liter.

When a patient's blood test on the fourth day came back below this number, the test was almost perfectly reliable in ruling out a leak. The study showed that if the level was under 137.3, there was a 98.9 percent chance the patient did not have an anastomotic leakage. This high level of certainty is crucial for doctors. It means that if a patient feels well and their blood test is low, they can likely be discharged home with confidence, avoiding unnecessary hospital days and anxiety. Conversely, if the level is above this threshold, it serves as a strong warning sign that further investigation is needed, even if the patient does not yet show obvious symptoms of infection.

The researchers also tested whether looking at the trend of the numbers over time was more useful than just looking at the single number on the fourth day. Some previous theories suggested that watching how the level changed from day two to day four might be a better predictor. However, this study found that the single measurement on the fourth day was actually superior. Tracking the rise and fall of the numbers did not provide better information than simply checking the absolute value on that specific day. This simplifies the process for medical teams, as they do not need to calculate complex changes between days to make a decision.

The study also revealed that this blood test behaves differently in certain patients. Specifically, the test was less reliable for patients who had a protective stoma created during their surgery. A stoma is an opening in the abdomen that diverts waste away from the new connection to help it heal. In these patients, the inflammation from a leak was often less severe, so the blood test did not rise as high as it did in other patients. This means that for patients with a stoma, a "normal" blood test result is not as reassuring, and doctors must rely more heavily on clinical judgment and other signs.

Furthermore, the researchers noted that while the fourth-day test is excellent for catching leaks that happen early, it cannot guarantee that a leak will never happen later. In this study, two patients developed leaks much later, on the thirteenth day after surgery, despite having low blood test results on the fourth day. This highlights that a low score on day four is a powerful tool for the immediate postoperative period, but it does not replace the need for patients to remain vigilant. If a patient feels unwell after leaving the hospital, they must seek medical attention regardless of what their earlier blood test showed.

Ultimately, this research provides a clear, evidence-based guide for a common and difficult clinical problem. By establishing a specific cutoff on the fourth day after minimally invasive bowel surgery, doctors can more confidently distinguish between a routine recovery and a serious complication. The findings suggest that a simple blood test can act as a powerful filter, allowing low-risk patients to recover at home while ensuring high-risk patients receive the urgent care they need. While the specific number needs to be confirmed in other hospitals and patient groups before becoming a universal standard, the study demonstrates that with the right timing and context, a single blood test can offer a high degree of safety and clarity in the complex aftermath of colorectal surgery.